Report Detail

Pharma & Healthcare Global TACE Embolic Microspheres Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4752277
  • |
  • 05 October, 2026
  • |
  • Global
  • |
  • 101 Pages
  • |
  • GIR
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global TACE Embolic Microspheres market size was valued at US$ 1623 million in 2025 and is forecast to a readjusted size of US$ 2819 million by 2032 with a CAGR of 8.3% during review period.
TACE embolic microspheres are a type of microsphere embolic agent used in transcatheter arterial chemoembolization (TACE) therapy. TACE stands for Transarterial Chemoembolization, which is a medical procedure used primarily in the treatment of liver cancer. It involves delivering chemotherapy drugs directly to a tumor in the liver while also blocking the blood supply to the tumor. This dual action helps to both directly attack the cancer cells and cut off their blood supply, thereby shrinking or slowing the tumor's growth. TACE embolic microspheres can be loaded with chemotherapy drugs (such as doxorubicin) or used alone to embolize (block) the blood vessels. By blocking these vessels, the microspheres prevent the tumor from receiving oxygen and nutrients, thereby reducing its ability to grow and survive.
In 2024, global TACE embolic microspheres production reached approximately 1186 L, with an average global market price of around US$1250 per ml. TACE embolic microspheres typically have a single-line production capacity of approximately 20-100 liters/year. The industry typically enjoys high gross profit margins of approximately 60% to 80%, primarily due to their high added value and technological barriers. Raw materials (polymers and drugs) account for the largest portion of the cost structure, approximately 30% to 40%, with the remainder comprising production consumables and packaging materials, labor costs, and manufacturing expenses. Upstream raw material suppliers provide key raw materials such as biodegradable polymers and drug-loaded materials. Downstream suppliers primarily include hospitals and medical institutions (as end users, performing TACE treatments) and dealers and distributors (responsible for regional product sales and promotion).
TACE embolic microsphere sector is transitioning from simple occlusion materials toward sophisticated drug-eluting and targeted-release platforms. Material innovation and drug-delivery design are enabling more predictable intratumoral exposure and procedure standardization, which aligns with clinicians’ demand for improved efficacy and safety. Regulatory acceptance and robust clinical evidence are the primary gates to wide hospital adoption; manufacturers that pair reproducible manufacturing with compelling clinical data will gain preferential uptake. Cost and supply considerations mean basic embolics will remain relevant in lower-resource settings, while high-value DEMs will dominate centers focused on outcome optimization. Overall, the market favors companies that integrate controlled-release technology, scalable production, and clinical partnerships.
This report is a detailed and comprehensive analysis for global TACE Embolic Microspheres market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global TACE Embolic Microspheres market size and forecasts, in consumption value ($ Million), sales quantity (L), and average selling prices (US$/mL), 2021-2032
Global TACE Embolic Microspheres market size and forecasts by region and country, in consumption value ($ Million), sales quantity (L), and average selling prices (US$/mL), 2021-2032
Global TACE Embolic Microspheres market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (L), and average selling prices (US$/mL), 2021-2032
Global TACE Embolic Microspheres market shares of main players, shipments in revenue ($ Million), sales quantity (L), and ASP (US$/mL), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for TACE Embolic Microspheres
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global TACE Embolic Microspheres market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boston Scientific, Terumo, Merit Medical, Varian, Sirtex Medical, Suzhou Hengrui Medical Equipment, ABK Biomedical, Mermaid Medical, Cardiolink Science, Suzhou Haowei Medical Technology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
TACE Embolic Microspheres market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Common Embolic Microspheres
Drug-Loadable Embolic Microspheres
Market segment by Size
1G (<100μm)
2 G (≥100μm)
Market segment by Application
Primary Liver Cancer
Colorectal Cancer Liver Metastasis
Others
Major players covered
Boston Scientific
Terumo
Merit Medical
Varian
Sirtex Medical
Suzhou Hengrui Medical Equipment
ABK Biomedical
Mermaid Medical
Cardiolink Science
Suzhou Haowei Medical Technology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe TACE Embolic Microspheres product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of TACE Embolic Microspheres, with price, sales quantity, revenue, and global market share of TACE Embolic Microspheres from 2021 to 2026.
Chapter 3, the TACE Embolic Microspheres competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the TACE Embolic Microspheres breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and TACE Embolic Microspheres market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of TACE Embolic Microspheres.
Chapter 14 and 15, to describe TACE Embolic Microspheres sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global TACE Embolic Microspheres Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Common Embolic Microspheres
    • 1.3.3 Drug-Loadable Embolic Microspheres
  • 1.4 Market Analysis by Size
    • 1.4.1 Overview: Global TACE Embolic Microspheres Consumption Value by Size: 2021 Versus 2025 Versus 2032
    • 1.4.2 1G (<100μm)
    • 1.4.3 2 G (≥100μm)
  • 1.5 Market Analysis by Application
    • 1.5.1 Overview: Global TACE Embolic Microspheres Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.5.2 Primary Liver Cancer
    • 1.5.3 Colorectal Cancer Liver Metastasis
    • 1.5.4 Others
  • 1.6 Global TACE Embolic Microspheres Market Size & Forecast
    • 1.6.1 Global TACE Embolic Microspheres Consumption Value (2021 & 2025 & 2032)
    • 1.6.2 Global TACE Embolic Microspheres Sales Quantity (2021-2032)
    • 1.6.3 Global TACE Embolic Microspheres Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Boston Scientific
    • 2.1.1 Boston Scientific Details
    • 2.1.2 Boston Scientific Major Business
    • 2.1.3 Boston Scientific TACE Embolic Microspheres Product and Services
    • 2.1.4 Boston Scientific TACE Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Boston Scientific Recent Developments/Updates
  • 2.2 Terumo
    • 2.2.1 Terumo Details
    • 2.2.2 Terumo Major Business
    • 2.2.3 Terumo TACE Embolic Microspheres Product and Services
    • 2.2.4 Terumo TACE Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Terumo Recent Developments/Updates
  • 2.3 Merit Medical
    • 2.3.1 Merit Medical Details
    • 2.3.2 Merit Medical Major Business
    • 2.3.3 Merit Medical TACE Embolic Microspheres Product and Services
    • 2.3.4 Merit Medical TACE Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Merit Medical Recent Developments/Updates
  • 2.4 Varian
    • 2.4.1 Varian Details
    • 2.4.2 Varian Major Business
    • 2.4.3 Varian TACE Embolic Microspheres Product and Services
    • 2.4.4 Varian TACE Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Varian Recent Developments/Updates
  • 2.5 Sirtex Medical
    • 2.5.1 Sirtex Medical Details
    • 2.5.2 Sirtex Medical Major Business
    • 2.5.3 Sirtex Medical TACE Embolic Microspheres Product and Services
    • 2.5.4 Sirtex Medical TACE Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Sirtex Medical Recent Developments/Updates
  • 2.6 Suzhou Hengrui Medical Equipment
    • 2.6.1 Suzhou Hengrui Medical Equipment Details
    • 2.6.2 Suzhou Hengrui Medical Equipment Major Business
    • 2.6.3 Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Product and Services
    • 2.6.4 Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Suzhou Hengrui Medical Equipment Recent Developments/Updates
  • 2.7 ABK Biomedical
    • 2.7.1 ABK Biomedical Details
    • 2.7.2 ABK Biomedical Major Business
    • 2.7.3 ABK Biomedical TACE Embolic Microspheres Product and Services
    • 2.7.4 ABK Biomedical TACE Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 ABK Biomedical Recent Developments/Updates
  • 2.8 Mermaid Medical
    • 2.8.1 Mermaid Medical Details
    • 2.8.2 Mermaid Medical Major Business
    • 2.8.3 Mermaid Medical TACE Embolic Microspheres Product and Services
    • 2.8.4 Mermaid Medical TACE Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Mermaid Medical Recent Developments/Updates
  • 2.9 Cardiolink Science
    • 2.9.1 Cardiolink Science Details
    • 2.9.2 Cardiolink Science Major Business
    • 2.9.3 Cardiolink Science TACE Embolic Microspheres Product and Services
    • 2.9.4 Cardiolink Science TACE Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Cardiolink Science Recent Developments/Updates
  • 2.10 Suzhou Haowei Medical Technology
    • 2.10.1 Suzhou Haowei Medical Technology Details
    • 2.10.2 Suzhou Haowei Medical Technology Major Business
    • 2.10.3 Suzhou Haowei Medical Technology TACE Embolic Microspheres Product and Services
    • 2.10.4 Suzhou Haowei Medical Technology TACE Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Suzhou Haowei Medical Technology Recent Developments/Updates

3 Competitive Environment: TACE Embolic Microspheres by Manufacturer

  • 3.1 Global TACE Embolic Microspheres Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global TACE Embolic Microspheres Revenue by Manufacturer (2021-2026)
  • 3.3 Global TACE Embolic Microspheres Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of TACE Embolic Microspheres by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 TACE Embolic Microspheres Manufacturer Market Share in 2025
    • 3.4.3 Top 6 TACE Embolic Microspheres Manufacturer Market Share in 2025
  • 3.5 TACE Embolic Microspheres Market: Overall Company Footprint Analysis
    • 3.5.1 TACE Embolic Microspheres Market: Region Footprint
    • 3.5.2 TACE Embolic Microspheres Market: Company Product Type Footprint
    • 3.5.3 TACE Embolic Microspheres Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global TACE Embolic Microspheres Market Size by Region
    • 4.1.1 Global TACE Embolic Microspheres Sales Quantity by Region (2021-2032)
    • 4.1.2 Global TACE Embolic Microspheres Consumption Value by Region (2021-2032)
    • 4.1.3 Global TACE Embolic Microspheres Average Price by Region (2021-2032)
  • 4.2 North America TACE Embolic Microspheres Consumption Value (2021-2032)
  • 4.3 Europe TACE Embolic Microspheres Consumption Value (2021-2032)
  • 4.4 Asia-Pacific TACE Embolic Microspheres Consumption Value (2021-2032)
  • 4.5 South America TACE Embolic Microspheres Consumption Value (2021-2032)
  • 4.6 Middle East & Africa TACE Embolic Microspheres Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global TACE Embolic Microspheres Sales Quantity by Type (2021-2032)
  • 5.2 Global TACE Embolic Microspheres Consumption Value by Type (2021-2032)
  • 5.3 Global TACE Embolic Microspheres Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global TACE Embolic Microspheres Sales Quantity by Application (2021-2032)
  • 6.2 Global TACE Embolic Microspheres Consumption Value by Application (2021-2032)
  • 6.3 Global TACE Embolic Microspheres Average Price by Application (2021-2032)

7 North America

  • 7.1 North America TACE Embolic Microspheres Sales Quantity by Type (2021-2032)
  • 7.2 North America TACE Embolic Microspheres Sales Quantity by Application (2021-2032)
  • 7.3 North America TACE Embolic Microspheres Market Size by Country
    • 7.3.1 North America TACE Embolic Microspheres Sales Quantity by Country (2021-2032)
    • 7.3.2 North America TACE Embolic Microspheres Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe TACE Embolic Microspheres Sales Quantity by Type (2021-2032)
  • 8.2 Europe TACE Embolic Microspheres Sales Quantity by Application (2021-2032)
  • 8.3 Europe TACE Embolic Microspheres Market Size by Country
    • 8.3.1 Europe TACE Embolic Microspheres Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe TACE Embolic Microspheres Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific TACE Embolic Microspheres Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific TACE Embolic Microspheres Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific TACE Embolic Microspheres Market Size by Region
    • 9.3.1 Asia-Pacific TACE Embolic Microspheres Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific TACE Embolic Microspheres Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America TACE Embolic Microspheres Sales Quantity by Type (2021-2032)
  • 10.2 South America TACE Embolic Microspheres Sales Quantity by Application (2021-2032)
  • 10.3 South America TACE Embolic Microspheres Market Size by Country
    • 10.3.1 South America TACE Embolic Microspheres Sales Quantity by Country (2021-2032)
    • 10.3.2 South America TACE Embolic Microspheres Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa TACE Embolic Microspheres Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa TACE Embolic Microspheres Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa TACE Embolic Microspheres Market Size by Country
    • 11.3.1 Middle East & Africa TACE Embolic Microspheres Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa TACE Embolic Microspheres Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 TACE Embolic Microspheres Market Drivers
  • 12.2 TACE Embolic Microspheres Market Restraints
  • 12.3 TACE Embolic Microspheres Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of TACE Embolic Microspheres and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of TACE Embolic Microspheres
  • 13.3 TACE Embolic Microspheres Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 TACE Embolic Microspheres Typical Distributors
  • 14.3 TACE Embolic Microspheres Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on TACE Embolic Microspheres. Industry analysis & Market Report on TACE Embolic Microspheres is a syndicated market report, published as Global TACE Embolic Microspheres Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of TACE Embolic Microspheres market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report